secwatch.observer — SEC 8-K summary
======================================

Issuer:     CURIS INC (CRIS)
CIK:        0001108205
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001108205-26-000002
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Curis raises up to $80.8M in PIPE financing; extends cash runway into 2027
--------------------------------------------------------------------------

- Initial gross proceeds of ~$20.2M from sale of Series B Preferred Stock and warrants; potential total up to ~$80.8M if warrants exercised.
- Warrants to purchase up to 26.9M shares each (Series A, B, C) at $0.75 exercise price; exercisable after stockholder approval.
- Proceeds expected to extend cash runway into 2027; focus on Phase 2 combo study of emavusertib in CLL and PCNSL.
- Purchasers include CEO, CFO, CMO, CDO and a board member.
- PIPE proceeds believed to sustain stockholders’ equity above Nasdaq $2.5M minimum; delisting hearing pending.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1108205/000110820526000002/0001108205-26-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1108205/000110820526000002/cris-20260107.htm
  HTML page:      https://secwatch.observer/filing/0001108205-26-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer